Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NEO -9.2%, JELD -3.3%, FLR -3.2%, CAG -3% (lowers FY25 guidance; unveils new innovations), HUN -2.5%, IHG -1.9%, BIDU -1.7%, MDT -1.4%, WAY -1.3%, ALLE -1%, DJT -0.9%, SPNS -0.8%,
Other news:
- RCUS -4% (reports new data demonstrating best-in-class potential for Casdatifan; prices offering of 13,636,364 shares of its common stock at an offering price of $11.00/share)
- DVAX -3.2% (enters into new supply agreement with West Pharmaceutical Services)
- WDS -2.1% (provides Sangomar update)
- SEE -1.4% (CEO Patrick Kivits steps down; Dustin Semach has been named CEO, effective immediately; co reaffirms prior guidance for FY24)